About the Company
springworks therapeutics is a mission-driven medicines company dedicated to developing innovative potential new treatments for unserved and underserved patient communities. originally conceived by pfizer, springworks presents a groundbreaking new model for collaboration rooted in connecting scientists, biopharmaceutical partners, patient groups, funders and philanthropists to advance and deliver transformative science to patients. through our partnerships, we remain focused on providing innovative treatments an additional avenue for development, with our launch pipeline focused on advancing potential programs for four diseases, all of which currently have no cure, including desmoid tumor, neurofibromatosis, hereditary xerocytosis and post-traumatic stress disorder. our name is a reflection of our approach to drug development: we’re springing into action to deliver treatments to people who are in great need and without alternatives.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SWTX News
Which Is a Better Investment, Alpine Immune Sciences Inc or SpringWorks Therapeutics Inc Stock?
Learn more about whether Alpine Immune Sciences Inc or SpringWorks Therapeutics Inc is a better investment based on AAII's A+ ...
SpringWorks Therapeutics Stock (NASDAQ:SWTX), Quotes and News Summary
SpringWorks Therapeutics Inc (NASDAQ: SWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announced the pricing of a publ Henry Khederian Why Titan Machinery Shares ...
SpringWorks Therapeutics Inc (SWTX) Reports Q4 and Full Year 2023 Financial Results
Warning! GuruFocus has detected 3 Warning Sign with SWTX. On February 27, 2024, SpringWorks Therapeutics Inc (NASDAQ:SWTX), a clinical-stage biopharmaceutical company, released its 8-K filing ...
Volatility Hits 4.73% At SpringWorks Therapeutics Inc (SWTX) – Here’s What A Good Investor Should Do
SWTX’s current price about 8.02% and 20.04% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 62.53, while 7-day volatility ratio is ...
SpringWorks Therapeutics Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
SpringWorks Therapeutics: Q4 Earnings Snapshot
STAMFORD, Conn. — STAMFORD, Conn. — SpringWorks Therapeutics Inc. (SWTX) on Tuesday reported a loss of $94.3 million in its fourth quarter. The Stamford, Connecticut-based company said it had ...
SpringWorks Therapeutics files patent for improved treatment methods using nirogacestat
Discover SpringWorks Therapeutics' innovative patent for treating desmoid tumors with nirogacestat, aiming to improve patient outcomes and quality of life.
SpringWorks Therapeutics gets grant for treatment of melanoma using specific pharmaceutical composition
Discover the groundbreaking patent by SpringWorks Therapeutics for treating melanoma with a specific compound, offering flexible dosing options for improved efficacy.
Loading the latest forecasts...